Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Northwest Biotherapeutics Inc (NASDAQ:NWBO)

1.94
Delayed Data
As of Feb 08
 -0.08 / -3.96%
Today’s Change
1.85
Today|||52-Week Range
12.55
-39.38%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Revenue and IncomeNet Revenues872.0K194.0K391.0K291.0K
 
 
 
 
 
Depreciation And Amortization--3.0K12.0K29.0K
 
 
 
 
 
Operating ExpensesGross Income872.0K191.0K----
 
 
 
General Expenses26.6M23.0M39.2M13.5M
 
 
 
 
 
Research And Development21.4M19.7M29.4M9.2M
 
 
 
 
 
Total Operating Expenses26.6M23.0M39.2M13.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-25.8M-22.8M-38.9M-13.2M
 
 
 
 
 
Extraordinary Credit449.0K0.000.0036.5M
 
 
 
Extraordinary Charge-17.2M-23.2M-25.7M--
 
 
 
 
Interest Expense On Debt570.0K793.0K1.6M1.0M
 
 
 
 
 
Other Expenses0.00349.0K-661.0K384.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-42.7M-46.4M-66.8M22.6M
 
 
 
 
 
Net Income-42.7M-46.4M-66.8M22.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS65.7M69.4M75.6M78.1M
 
 
 
 
 
Shares To Calculate EPS Diluted65.7M69.4M75.6M89.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.65-$0.67-$0.88$0.25
 
 
 
 
 
EPS Diluted-$0.65-$0.67-$0.88$0.25